-- Alan Mozes
WEDNESDAY, May 22 (HealthDay News) -- Roughly four in 10
uninsured patients who have been diagnosed with chronic obstructive
pulmonary disease (COPD) actually do not have the lung disease, a
small new study suggests.
At issue: Faulty diagnoses were made based on an evaluation of
symptoms, rather than by means of the so-called "gold standard"
disease test known as spirometry, which shows how well a patient's
lungs are working by measuring the amount of air they can exhale
and how long that takes.
The study is scheduled for presentation Wednesday at the
American Thoracic Society annual meeting in Philadelphia. The data
and conclusions should be viewed as preliminary until published in
a peer-reviewed journal.
COPD is a progressive disease that makes it hard to breathe.
Symptoms include coughing, wheezing, shortness of breath and chest
tightness, according to the U.S. National Heart, Lung, and Blood
Institute. Cigarette smoking is the top cause of COPD.
"While there have been many studies of the under-diagnosis of COPD, there has not been a U.S.-based study that has quantified the problem of over-diagnosis," Dr. Christian Ghattas, a second-year medical resident at Saint Elizabeth Health Center in Youngstown, Ohio, said in a society news release. "And yet, the cost of treating someone for COPD is high."
How high? The study team cited statistics suggesting the cost
exceeds $4,100 per year.
The researchers re-evaluated 80 patients, average age 53, being
treated at a federally funded health center based in Akron, Ohio,
that is designed to offer medical care to the uninsured and
Medicaid patients. All the patients had been diagnosed in 2011 or
2012 as having COPD or as needing an inhaler device often given to
Investigators found that less than 18 percent of the patients
had undergone spirometry testing, despite a Global Obstructive Lung
Disease recommendation that COPD not be diagnosed without such a
Once conducted, spirometry testing revealed that nearly 43
percent of the patients did not have any obstruction that could be
construed as COPD.
What's more, another quarter of the patients had a reversible
condition that is more typical of asthma than COPD.
"We were shocked at the percentage," Ghattas said. He noted that, overall, probably half the patients were misdiagnosed.
"Although the number of patients in our study was small, I believe this study is representative of an uninsured and underserved patient population," he added. "However, the findings might be different among patients who are insured. They might be higher or lower. We simply don't know," Ghattas said.
But, "it is obviously detrimental to be on medications that
won't work for you," Ghattas cautioned. "You won't feel better --
and that by itself can take a psychological toll -- and you may
experience side effects that can compromise other aspects of your
For more on COPD, visit the
U.S. National Heart, Lung, and Blood
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.